Publication: 102

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 26 (34) 5603-5609
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
416  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
CA-37404, CA-35431, CA-35195, CA-114740, CA-35103, CA-25224, CA-60276, CA-108961, R01 CA127716, CA-35113, CA-63848, CA-37417, CA-35269, CA-35101, CA-35267, CA-63849  
Corr. Author:
 
Authors:
                                       
Networks:
 
Study
NCCTG-N0177
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Neurooncology